Sentences with phrase «therapeutic advances in»
He instructed courses at the 2012 Symposium for Therapeutic Advances in Animal Rehabilitation on Neurological Rehab and also on Massage and Manual Therapy for Healing, Pain Reduction, and Restoration of Motion.
http://www.caninerehab.com/
Therapeutic Advances in Gastroenterology, 2009 2:169 - 181.
A study looking into the therapeutic effects of prolotherapy for moderate knee osteoarthritis was published in the April 2015 issue of Therapeutic Advances in Musculoskeletal Disease.
In addition, we have access to new agent trials through the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) consortium, and we offer CAR T - cell therapy for eligible children with relapsed or refractory acute lymphoblastic leukemia (ALL).
«There have been few therapeutic advances in the past 30 years and platinum - based chemotherapy remains the standard of care.
Such work is accelerating therapeutic advances in autoimmunity, solid organ transplantation, and cancer immunotherapy.
Therapeutic advances in medical oncology.
Angiotensin II signalling and calcineurin in cardiac fibroblasts: differential effects of calcineurin inhibitors FK506 and cyclosporine A. Therapeutic Advances in Cardiovascular Disease, 6 (1), 5 — 14.
Not exact matches
Robots are eliminating job drudgery in hospitals, and as technology advances, they'll take on therapeutic roles too.
In November 2001, scientists from Advanced Cell Technologies, a biotechnology company in Massachusetts, announced that they had cloned the first human embryos for the purpose of advancing therapeutic researcIn November 2001, scientists from Advanced Cell Technologies, a biotechnology company in Massachusetts, announced that they had cloned the first human embryos for the purpose of advancing therapeutic researcin Massachusetts, announced that they had cloned the first human embryos for the purpose of advancing therapeutic research.
The findings by a team of Massachusetts General Hospital (MGH) investigators, which will be published in the April 24 issue of Cell and are receiving advance online release, support the importance of epigenetics — processes controlling whether or not genes are expressed — in cancer pathology and identify molecular circuits that may be targeted by new therapeutic approaches.
Given the importance of ATP synthase in fueling the cell, determining the complete structure of the enzyme has been a scientific holy grail, promising to reveal secrets about the ATP machine that could lead to therapeutic target identification and advance understanding of metabolic disease and other cellular pathologies.
Other UT Southwestern faculty members who contributed to this research are: Dr. Boning Gao, Assistant Professor with the Hamon Center for Therapeutic Oncology Research and Pharmacology; Dr. Kimmo Hatanpaa, Associate Professor of Pathology; Dr. Kemp Kernstine, Professor of Cardiovascular and Thoracic Surgery and holder of the Robert Tucker Hayes Foundation Distinguished Chair in Cardiothoracic Surgery; Dr. Yang Xie, Associate Professor of Clinical Sciences and Bioinformatics; Dr. Hong Zhu, Assistant Professor of Clinical Sciences and with the Simmons Cancer Center; Dr. Farjana Fattah, Assistant Professor with the Simmons Cancer Center and Pathology; Dr. Masaya Takahashi, Associate Professor with the Advanced Imaging Research and Radiology; Dr. Bipasha Mukherjee, Assistant Professor of Radiation Oncology; Dr. Sandeep Burma, Associate Professor of Radiation Oncology; and Dr. Jonathan Dowell, Professor of Internal Medicine;
«We are excited by the work of Dr. Pourdehnad and colleagues and believe these results are an important advance in understanding the role of myc pathway dysregulation in multiple myeloma, and ultimately allow for the development of therapeutic strategies to address it,» said Jeffrey Wolf, MD, a UCSF blood disorder specialist and director of the Stephen and Nancy Grand Multiple Myeloma Translational Initiative at UCSF, a sponsor of the research.
And its Defense Sciences Office (DSO) has aligned with President Barack Obama's Brain Research through Advancing Innovative Neurotechnologies Initiative, calling for grant applications on projects to design therapeutic devices for neurological disorders and to repair brain damage in military service members.
After a successful postdoc at the Ontario Cancer Institute, where he developed a proprietary platform for the discovery of novel cancer therapeutic agents, Bray was asked to join the former Amgen Research Institute in Toronto (now called the Advanced Medical Discovery Institute and no longer part of the parent company) as the head of their quantitative biology group and act as liaison to Amgen Inc. in California.
The growing therapeutic use of NO along with technological advances including the availability of miniaturized electronic circuitry allowed the MGH team to develop the system described in the current report.
Other UT Southwestern researchers involved in the study were Dr. Ramzi Abdulrahman, Associate Professor of Radiation Oncology; Dr. Arthur Sagalowsky, Professor of Urology and Surgery, co-leader of the Kidney Cancer Program, who holds The Dr. Paul Peters Chair in Urology in Memory of Rumsey and Louis Strickland; Dr. Ivan Pedrosa, Associate Professor of Radiology and the Advanced Imaging Research Center, co-leader of the Kidney Cancer Program, who holds the Jack Reynolds, M.D., Chair in Radiology; Dr. Hak Choy, Chair and Professor of Radiation Oncology who holds The Nancy B. & Jake L. Hamon Distinguished Chair in Therapeutic Oncology Research; and Dr. James Brugarolas, Associate Professor of Internal Medicine and Developmental Biology, leader of the Kidney Cancer Program, and Virginia Murchison Linthicum Endowed Scholar; and other researchers including Stephen Chun, Dr. Nathan Cannon, and Dr. Nathan Kim.
Discovering New Therapeutic Uses for Existing Molecules, announced in early May, is the first major initiative from NIH's new National Center for Advancing Translational Science (NCATS).
The study of these new mouse models means an advance in the knowledge of disease's development mechanisms and an opportunity to implement new therapeutic strategies for patients.
D. student Bridget A. Quinn has played a critical role in advancing this novel therapeutic concept.
With genetically engineered microorganisms, such as bacteria and fungi, playing an increasing role in the green chemistry production of valuable chemical products including therapeutic drugs, advanced biofuels and biodegradable plastics from renewables, Cas9 is emerging as an important genome - editing tool for practitioners of synthetic biology.
In this case, zebrafish were critical for advancing our understanding of Jagged function in the liver, allowing us to devise new therapeutic strategies for Alagille Syndrome.&raquIn this case, zebrafish were critical for advancing our understanding of Jagged function in the liver, allowing us to devise new therapeutic strategies for Alagille Syndrome.&raquin the liver, allowing us to devise new therapeutic strategies for Alagille Syndrome.»
George Ebers, an MS researcher at Oxford University in the U.K., says that the new findings are «important conceptually» but may not easily translate into therapeutic advances.
Interactive sessions will present basic and clinic research focusing on advances in virology, therapeutic drug development and practical -LRB-...)
Affineti Biologics, Inc. is advancing its research in the development of therapeutic and diagnostic products based on new discoveries in oral biology and dental medicine.
new technological advances in the field of live imaging [e.g. magnetic resonance imaging (MRI) and optical in - vivo imaging] to develop new preventive and / or therapeutic approaches for these diseases.
Toronto and Vancouver, Canada - Zucara Therapeutics Inc., a diabetes life sciences company advancing the first once - daily therapeutic to prevent low blood glucose levels (hypoglycemia), has secured US$ 3.9 million in non-dilutive funding from The Leona M. and Harry B. Helmsley Charitable Trust.
«We are excited to continue to advance the use of the technology in promising areas in the therapeutic space, research use, agricultural biotechnology and industry biotechnology through collaborations with established market leaders.»
«To advance our internal programs in genetic rare diseases and oncology and support partners in many additional therapeutic areas, we are building an R&D organization that is second to none.
Quantitative Flow Cytometry in Cell Therapy Ines Mende, PhD, Hitachi Chemical Advanced Therapeutic Solutions, LLC
The symposium brings together leaders in biology, medicine, and industry to present on the latest advances in technology development, mechanistic understanding, and therapeutic application of stem cells for both drug development and cell - based therapy.
«This collaboration has already resulted in exciting new capabilities and insights for R&D for small airway diseases, and we look forward to further advancing the application of the Organ - Chips to improve therapeutic development».
Advances in Arrhythmia and Electrophysiology Therapeutic Strategies for Long - QT Syndrome Does the Molecular Substrate Matter?
The Biology of Aging: Advances in Therapeutic Approaches to Extend Healthspan; SCRIPPS, Jupiter, FL, January 22 - 25, 2017
Overall, despite the dramatic therapeutic advances made elsewhere in the melanoma field, the poor prognosis of patients with mucosal melanoma mandates continued emphasis on laboratory and clinical research efforts in this rare subset of disease.
The advanced stem cell therapy protocol available at Okyanos, which is currently not being offered in the United States, is an important therapeutic option for the skin manifestations of this type of systemic scleroderma.
We're using this advanced biomarker imaging endpoints as part of our way to detect whether the therapeutic is having a positive effect early in the trial.
Dr. Sato's current research area is in the field of regulatory science for the quality and safety of advanced therapeutic products.
In the advanced - stage melanoma setting, therapeutic approaches for patients who have failed prior approved treatments are critically needed.
Results from these studies will provide direct evidence for the importance of these nutritional factors in maintaining retinal health and preventing advanced retinal disease, and may reveal new options for therapeutic intervention.
These pre-clinical results are encouraging and demonstrate a fascinating approach to bringing improved patient outcomes that would enable rapid advances in precision medicine and therapeutic stratification in the future.»
Goya et al. «Recent Advances in Cannabinoid Receptor Agonists and Antagonists», Expert Opinion on Therapeutic Patents, 10 (10): 1529 - 1538, 2000.
«Our study demonstrates a new therapeutic approach to successfully target inflammation and fibrosis, representing a major advance in the field,» concluded Haldar.
A therapeutic cervical cancer vaccine was developed and tested in women with advanced disease.
Madsen's research focuses on the use of lasers in diagnostic and therapeutic medicine, the goal of which is to develop better treatments for patients with advanced brain tumors.
Since then, he has made important genetic, mechanistic, and clinical discoveries related to skeletal dysplasias and urea cycle disorders, translated these discoveries into therapeutic advances, and tested these therapies in clinical trials.
For advanced imaging applications such as optical fluorescence tomography and photoacoustic (or optoacoustic) tomography the effective diagnostic and therapeutic window is in the 650 — 900 nm range [6].
To translate advances in our understanding of molecular mechanisms of oncogenesis and tumor progression into novel therapeutic strategies.With primary focus on lung cancer, melanoma, and lymphoma / leukemia, we will use the strength of in - depth molecular and phenotypic characterization of tumor heterogeneity to identify new targets and translate those into new therapeutic opportunities.
Clinical and Regenerative medicine refers to development and implementation of advanced therapeutic approaches that may involve the support of expertise in gene / cell therapy, tissue engineering, pharmacology and pharmacogenomics, development of novel molecular target therapy.